Search

everythinglearnresearchcommunity

for

Search:↓

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Artefactual skin disorder involves self-inflicted skin lesions linked to mental health issues, needing combined medical and psychological treatment.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

Different medications can cause serious side effects in some people.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.